Clinical Trial Update: Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing lixisenatide for restoration of insulin release in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED